SEARCH

SEARCH BY CITATION

  • 1
    Fantone JC. Pathogenesis of ischemia-reperfusion injury: an overview. In: ZelenockGB, ed. Clinical ischemic Syndromes: Mechanisms and Consequences of Tissue Injury. St. Louis : The C. V. Mosby Company; 1990:137145.
  • 2
    Grum CM. Cellular energetics. In: ZelenockGB, ed. Clinical Ischemic Syndromes: Mechanisms and Consequences of Tissue Injury. St. Louis : The C. V. Mosby Company, 1990;4762.
  • 3
    Southard JH. Temperature effects and cooling. In: ZelenockGB, ed. Clinical Ischemic Syndromes: Mechanisms and Consequences of Tissue Injury. St. Louis : The C. V. Mosby Company; 1990;303325.
  • 4
    Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Radical Biology & Medicine 1988;5:409419.
  • 5
    Bannister JV, Bannister WH, Rotilio G. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit Rev Biochem 1987; 22:111180.
  • 6
    Flohe L. Glutathione peroxidase brought into focus. In: PryorWA, ed. Free Radicals in Biology. New York , NY : Academic Press; 1980:223254.
  • 7
    Hitt ME. Oxygen-derived free radicals: Pathophysiology and implications. Compend Contin Educ Pract Vet 1988; 10:939945.
  • 8
    Ernster L. Biochemistry of reoxygenation injury. Crit Care Med 1988;16:947953.
  • 9
    Klebanoff SS. Products of oxygen metabolism. In: GallinJI, GoldsteinIM, SnyderR., ed. Basic Principles and Clinical Correlates. New York , NY : Raven Press; 1988;391444.
  • 10
    Krawisz JE, Sharon P., Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984; 87:13441350.
  • 11
    Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986;251:G567G574.
  • 12
    Grisham MB, Granger DN. Neutrophil-mediated mucosal injury: Role of reactive oxygen metabolites. Digestive Diseases and Sciences 1988;33:6S15S (suppl).
  • 13
    Jarasch E., Bruder G., Heid HW. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand 1986; 548: 3946.
  • 14
    Batelli MG, Corte ED, Stirpe E. Xanthine oxidase type D (dehydrogenase) in the intestine and other organs of the rat. Biochem J 1972; 126:747749.
  • 15
    Cohen MV. Free radicals in ischemic and reperfusion myocardial injury: A selective review. Ann Int Med 1989; 111:918931.
  • 16
    Otamiri TA. Influence of quinacrine on plasma malondial-dehyde after small intestinal ischemia and reperfusion. Circ Shock 1988;24:6369.
  • 17
    Parks DA, Bulkley GB, Granger DN, et al. Ischemic injury in the cat small intestine: Role of superoxide radicals. Gastroenterology 1982;82:915.
  • 18
    Parks DA, Shah AK, Granger DN. Oxygen radicals: effects on intestinal vascular permeability. Am J Physiol 1984;247:G167G170.
  • 19
    Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 1986;250: G749G753.
  • 20
    Granger DN, Hollwarth M., Parks DA. Ischemia-reperfusion injury, role of oxygen-derived free radicals. Acta Physiol Scand 1986;548:4763.
  • 21
    Granger DN, McCord JM, Parks DA, et al. Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine. Gastroenterology 1986;90:8084.
  • 22
    Parks DA, Bulkley GB, Granger DN. Role of oxygen free radicals in shock, ischemia, and organ preservation. Surgery 1983;94:429432.
  • 23
    Hernandez LA, Grisham MB, Granger DN. A role for iron in oxidant-mediated ischemic injury to intestinal microvasculature. Am J Physiol 1987;253:G49G53.
  • 24
    Smith SM, Grisham MB, Manci EA, et al. Gastric mucosal injury in the rat: Role of iron and xanthine oxidase. Gastroenterology 1987;92:950956.
  • 25
    Perry MA, Wadhwa S., Parks DA, et al. Role of oxygen radicals in ischemia-induced lesions in the cat stomach. Gastroenterology 1986;90:362367.
  • 26
    Grogaard B., Parks DA, Granger DN, et al. Effects of ischemia and oxygen radicals on mucosal albumin clearance in intestine. Am J Physiol 1982;242:G448G454.
  • 27
    Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992;262.
  • 28
    Carey C., Siegfried MR, Ma X., et al. Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ Shock 1992;38:209216.
  • 29
    Granger DN, Benoit JN, Suzuki M., et al. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989;257:G683G688.
  • 30
    Suzuki M., Inauen W., Kvietys PR, et al. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am J Physiol 1989;257:H1740H1745.
  • 31
    Zimmerman BJ, Grisham MB, Granger DN. Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 1990;258:G185G190.
  • 32
    Hernandez LA, Grisham MB, Twohig B., et al. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987;253:H699H703.
  • 33
    Sekizuka E., Benoit JN, Grisham MB, et al. Dimethylsulfoxide prevents chemoattractant-induced leukocyte adherence. Am J Physiol 1989;256:H594H597.
  • 34
    Kubes P., Hunter J., Granger DN. Ischemia/reperfusion-induced feline intestinal dysfunction: Importance of granulocyte recruitment. Gastroenterology 1992; 103:807812.
  • 35
    Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255:H1269H1275.
  • 36
    Zimmerman BJ, Granger DN. Reperfusion-induced leukocyte infiltration: role of elastase. Am J Physiol 1990;259:H390H394.
  • 37
    Brown MF, Ross AJ, Dasher J., et al. The role of leukocytes in mediating mucosal injury of intestinal ischemia/reperfusion. J Ped Surg 1990;25:214217.
  • 38
    Zimmerman BJ, Guillory DJ, Grisham MB, et al. Role of leukotriene B4 in granulocyte infiltration into the postischemic feline intestine. Gastroenterology 1990;99:13581363.
  • 39
    Kubes P., Ibbotson G., Russell J., et al. Role of platelet-activating factor in ischemia-reperfusion-induced leukocyte adherence. Am J Physiol 1990;259:G300G305.
  • 40
    Luscinskas FW, Brock AF, Arnaout MA, et al. Endothelialleukocyte adhesion molecule-1 dependent and leukocyte (CD 11/CD 18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J Immunol 1989; 142:22572263.
  • 41
    Lo SK, Van Seventer GA, Levin SM, et al. Two leukocyte receptors (CD 11a/CD 18 and CD 11b/CD 18) mediate transient adhesion to endothelium by binding to different ligands. J Immunol 1989; 143:33253329.
  • 42
    Tonnesen MG, Smedly LA, Henson PM. Neutrophil endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formylmethionyl-leucyl-phenylalanine in vitro. J Clin Invest 1984;74: 15811592.
  • 43
    Tonnesen MG, ANderson DC, Springer TA, et al. Adherence of neutrophils to cultured human microvascular endothelial cells: Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95. J Clin Invest 1989; 83:637646.
  • 44
    Vedder NB, Harlan JM. Increased surface expression of CD 11b/CD 18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest 1988;81:676682.
  • 45
    Vedder NB, Winn RK, Rice CL, et al. A monoclonal antibody to the adherence promoting leukocyte glycoprotein, CD 18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest 1988;81:939944.
  • 46
    Rothlein R., Dustin ML, Marlin SD, et al. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986; 137:12701274.
  • 47
    Cybulsky MI, McComb DJ, Movat HJ. Protein synthesis dependent and independent mechanisms of neutrophil emigration: Different mechanisms of inflammation in rabbits induced by in-terleukin-1, tumore necrosis factor alpha of endotoxin versus leukocyte chemoattractants. Am J Pathol 1989; 135:227237.
  • 48
    Otamiri T., Franzen L., Lindmark D., et al. Increased phospholipase A2 and decreased Isyophospholipase activity in the small intestinal mucosa after ischaemia and revascularization. Gut 1987;28:14451453.
  • 49
    Otamiri T., Sjodahl R., Tagesson C. Lysophosphatidylcholine potentiates the increase in mucosal permeability after small intestinal ischaemia. Scand J Gastroenterol 1986;21:11311136.
  • 50
    Gonzalez-Crussi F., Hsueh W. Experimental model of ischaemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am J Pathol 1983;112: 127135.
  • 51
    Otamiri T., Lindahl M., Tagesson C. Phospholipase A2 inhibition prevents mucosal damage associated with small intestinal ischemia in rats. Gut 1988;29:489494.
  • 52
    Hansen B. Leukotrienes: Biology and role in disease. J Vet Int Med 1989; 3:5972.
  • 53
    Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem 1986;55:483509.
  • 54
    Filep J., Herman F., Braquet P., et al. Increased levels of platelet activating factor in blood following intestinal ischemia in the dog. Biochem Biophys Res Commun 158:353359, 1989.
  • 55
    Esplugues JV, Whittle BJR. Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat. Br J Pharmacol 1988;93:222228.
  • 56
    Kubes P., Suzuki M., Granger DN. Platelet-activating factor-induced microvascular dysfunction: role or adherent leukocytes. Am J Physiol 1990;258:G158G163.
  • 57
    Kubes P., Grisham MB, Barrowman JA, et al. Leukocyte-induced vascular protein leakage in cat mesentery. Am J Physiol 1991;261:H1872H1879.
  • 58
    Inauen W., Granger DN, Meininger CJ, et al. Anoxia-repxygenation-induced, neutrophil-mediated endothelial cell injury: role of elastase. Am J Physiol 1990;259:H925H931.
  • 59
    Cueva JP, Hsueh W. Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis. Gut 1988;29: 12071212.
  • 60
    Mangino MJ, Anderson CB, Murphy MK, et al. Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury. Am J Physiol 1989;257:G299G307.
  • 61
    Goldman G., Welbourn R., Klausner JM, et al. Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1. Circ Res 1991;68:10131019.
  • 62
    Karasawa A., Guo J., Ma X., et al. Protective actions of a leukotriene B4 antagonist in splanchnic ischemia and reperfusion in rats. Am J Physiol 1991;261:G191G198.
  • 63
    Borgstrom A., Haglund UH. Proteases: role in mucosal injury. In: MarstonA., BulkleyGB, Fiddian-GreenRG, HaglundUH, ed. Splanchnic Ischemia and Multiple Organ Failure. St. Louis , MO : Mosby; 1989:159165.
  • 64
    Bounous G., Menard D., De Medicis E. Role of pancreatic proteases in the pathogeriesis of ischemic enteropathy. Gastroenterology 1977;73:102108.
  • 65
    Parks DA, Granger DN, Bulkley GB, et al. Soybean trypsin inhibitor attenuates ischemic injury to the feline small intestine. Gastroenterology 1985;89:612.
  • 66
    Granger DN, Rutili G., McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981;81:2229.
  • 67
    Meakins JL, Marshall JC. The gut as the motor of multiple system organ failure. In: MarstonA., BulkleyGB, Fiddian-GreenRG, ed. Splanchnic Ischemia and Multiple Organ Failure. London : Edward Arnold, 1989;339.
  • 68
    Horton JW, White DJ. Cardiac contractile injury after intestinal ischemia-reperfusion. Am J Physiol 1991;261:H1164H1170.
  • 69
    Schmeling DJ, Caty MG, Oldham KT, et al. Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery 1989; 106:195201.
  • 70
    Caty MG, Guice KS, Oldham KT, et al. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1990;212:694700.
  • 71
    Koike K., Moore EE, Moore FA, et al. Phospholipase A2 inhibition decouples lung injury from gut ischemia-reperfusion. Surgery 1992;112:173180.
  • 72
    Henninger DW, Snyder JR, Pascoe JR, et al. Microvascular permeability changes in ischemia-reperfusion injury in the ascending colon of horses. JAVMA 1992;201:11911196.
  • 73
    Morris DD. Recognition and management of disseminated intravascular coagulation in horses. Vet Clin North Am: Equine Practice 1988;4:115143.
  • 74
    Pablo LS, Purhoit RC, Teer PA, et al. Disseminated intravascular coagulation in experimental intestinal strangulation obstruction in ponies. Am J Vet Res 1983;44:21152121.
  • 75
    Prasse KW, Topper MJ, Moore JN, et al. Analysis of hemostasis in horses with colic. J Am Vet Med Assoc 1993; 203:685693.
  • 76
    Duncan SG, Meyers KM, Reed SM, et al. Alterations in coagulation and hemograms of horses given endotoxins for 24 hours via hepatic portal infusions. Am J Vet Res 1985;46:12871293.
  • 77
    Chiu CJ, McArdle AH, Brown R., et al. Intestinal mucosal lesions in low-flow states. I. A morphological, hemodynamic and metabolic reappraisal. Arch Surg 1970;101: 478483.
  • 78
    Parks DA, Grogaard B., Granger DN. Comparison of partial and complete arterial occlusion models for studying intestinal ischemia. Surgery 1982;92:896901.
  • 79
    Kvietys PR, Granger DN. Hypoxia: its role in ischemic injury to the intestinal mucosa. In: MarstonA., BulkleyGB, Fiddian-GreenRG, HaglundUH, ed. Splanchnic ischemia and multiple organ failure. St. Louis : The C. V. Mosby Company; 1989:127134.
  • 80
    MacDonald MH, Pascoe JR, Stover SM et al. Survival after small intestine resection and anastomosis in horses. Vet Surg 1989; 18:415423.
  • 81
    Pascoe PJ, McDonell WN, Trim CM, et al. Mortality rates and associated factors in equine colic operations - A retrospective study of 341 operations. Can Vet J 1983;24:7685.
  • 82
    White NA. Pathophysiology and principles of therapy: Pathophysiology of obstruction, strangulation and strangulation/obstruction ischemia. In: ColahanPT, MayhewIG, MerrittAJ, MooreJN, eds. Equine Medicine and Surgery. Goleta , CA : American Veterinary Publications; 1990:490498.
  • 83
    Snyder JR. The pathophysiology of intestinal damage: Effects of luminal distension and ischemia. Vet Clin North Am Equine Pract 1989;5:247270.
  • 84
    White NA, Moore JN, Trim CM. Mucosal alterations in experimentally induced small intestinal strangulation obstruction in ponies. Am J Vet Res 1980;41:193198.
  • 85
    Barker IK, Van Dreumel AA. The alimentary system. In: JubbW., KennedyPC, PalmerN., ed. Pathology of Domestic Animals. New York , NY : Academic Press; 1985:6066.
  • 86
    Snyder JR, Olander HJ, Pascoe JR, et al. Morphologic alterations observed during experimental ischemia of the equine large colon. Am J Vet Res 1988;49:801809.
  • 87
    Snyder JR, Pascoe JR, Olander HJ, et al. Ultrastructural mucosal injury after experimental ischemia of the ascending colon in horses. Am J Vet Res 1992;53:19171924.
  • 88
    Snyder JR, Pascoe JR, Olander HJ, et al. Strangulating volvulus of the ascending colon in horses. J Am Vet Med Assoc 1989; 195:757764.
  • 89
    Allen DA, Tyler D. Pathophysiology of acute abdominal disease. In: WhiteNA, ed. The Equine Acute Abdomen. Philadelphia , PA : Lea & Febiger; 1990:6687.
  • 90
    Barclay WP, Foerner JJ, Phillips TN. Volvulus of the large colon in the horse. J Am Vet Med Assoc 1980; 177:629630.
  • 91
    Harrison IW. Equine large intestinal volvulus: A review of 124 cases. Vet Surg 1988;17:7781.
  • 92
    Meschter CL. Histopathological findings in the gastrointestinal tract of horses with colic. Am J Vet Res 1986;47:598606.
  • 93
    Arden WA, Slocombe RF, Stick JA, et al. Morphologic and ultrastructural evaluation of effect of ischemia and dimethyl sulfoxide on equine jejunum. Am J Vet Res 1990;51:17841791.
  • 94
    Freeman DE, Cimprich RE, Richardson DW, et al. Early mucosal healing and chronic changes in pony jejunum after various types of strangulation obstruction. Am J Vet Res 1988;49:810817.
  • 95
    Home MH, Pascoe PJ, Ducharme NG, et al. Attempts to modify reperfusion injury of equine jejunal mucosa using dimethylsulfoxide, allopurinol, and intraluminal oxygenation. Vet Surg 1994;23:241249.
  • 96
    Moore RM, Bertone AI, Muir WW, et al. Histopathologic evidence of reperfusion injury in the large colon of horses after low-flow ischemia. Am J Vet Res 1994;55:14341443.
  • 97
    Moore RM, Muir WW, Bertone AI, et al. Characterization of the hemodynamic and metabolic alterations in the large colon of horses during low-flow ischemia and reperfusion. Am J Vet Res 1994;55:14441453.
  • 98
    Moore RM, Bertone AI, Bailey MQ, et al. Neutrophil accumulation in the large colon of horses during low-flow ischemia and reperfusion. Am J Vet Res 1994;55:14541463.
  • 99
    Moore RM, Hardy J., Muir WW. Mural blood flow distribution in the large colon of horses during low-flow ischemia and reperfusion. Am J Vet Res 1994 (in press).
  • 100
    Moore RM, Muir WW, Cawrse MA. Colonic and systemic venous plasma endotoxin and prostaglandin concentration and colonic venous serum tumor necrosis factor and interleukin-6 activity in horses during low-flow ischemia and reperfusion of the large colon. Am J Vet Res 1994 (in press).
  • 101
    Provost PJ, Stick JA, Patterson JS, et al. Effects of heparin treatment on colonic torsion-associated hemodynamic and plasma eicosanoid changes in anesthetized ponies. Am J Vet Res 1991;52: 289297.
  • 102
    Reeves MJ, Vansteenhouse J., Stashak TS, et al. Failure to demonstrate reperfusion injury following ischaemia of the equine large colon using dimethyl sulphoxide. Equine Vet J 1990;22:126132.
  • 103
    Sullivan KE, Snyder JR, Shiedt MJ, et al. Lipid peroxidation and antioxidative defences during ischaemia and reperfusion of the equine ascending colon. Equine Vet J 1992;13:99101 (suppl).
  • 104
    Vatistas NJ, Snyder JR, Hildebrand SV, et al. Effects of the 21-aminosteroid U-74389G on ischemia and reperfusion injury of the ascending colon in horses. Am J Vet Res 1993;54:21552160.
  • 105
    Meschter CL, Craig D., Hackett R. Histopathological and ultrastructural changes in simulated large colonic torsion and reperfusion in ponies. Equine Vet J 1991;23:426433.
  • 106
    Moore RM. Large colon ischemia-reperfusion injury in the horse. The Ohio State University, 1994, PhD Dissertation.
  • 107
    Schlipf JW, Getzy DM, Stashak TST-D JL. The effects of allopurinol on postischemic reperfusion of the large colon of the horse. Proc 12th ACVIM Forum 1994;1017.
  • 108
    Freeman DE, Johnston JK. Failure of superoxide dismutase to mitigate changes cauxed by ischemia and reperfusion in horse intestine. 27th Annual ACVS Scientific Meeting 1992;32.
  • 109
    Prichard M., Ducharme NG, Wilkins PA, et al. Xanthine oxidase formation during experimental ischemia of the equine small intestine. Can J Vet Res 1991;55:310314.
  • 110
    Johnston JK, Freeman DE, Gillette D., et al. Effects of superoxide dismutase on injury by anoxia and reoxygenation in equine small intestine in vitro. Am J Vet Res 1991;52:20502054.
  • 111
    Wilkins PA, Ducharme NG, Lowe JE, et al. Measurements of blood flow and xanthine oxidase activity during postischemic reperfusion of the large colon of ponies. Am J Vet Res 1994; 55:11681177.
  • 112
    Shandall AA, Williams GT, Hallet MB. Colonic healing: a role for polymorphonuclear leukocytes and oxygen radical production. Br J Surg 1986;73:225228.
  • 113
    Moore RM, Bertone AI, Muir WW, et al. Effects of dimethyl sulfoxide, allopurinol, 21-aminosteroid U-74389G, and manganese chloride on large colon ischemia-reperfusion injury in the horse. Am J Vet Res 1994 (in press).
  • 114
    Spector T., Hall WW, Krenitsky TA. Human and bovine xanthine oxidases; inhibition studies with oxypurinol. Biochem Pharmacol 1986;35:31093114.
  • 115
    Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: A reevaluation. Am J Physiol 1988;254:G768G774.
  • 116
    Megison SM, Horton JW, Chao H., et al. Prolonged survival and decreased mucosal injury after low-dose enteral allopurinol prophylaxis in mesenteric ischemia. J Ped Surg 1990;25:917921.
  • 117
    Garcia JG, Rollan CM, Enrinquez MAR, et al. Improved survival in intestinal ischemia by allopurinol not realted to xanthine-oxidase inhibition. J Surg Res 1990;48:144146.
  • 118
    Moorhouse PC, Gootweld M., Haliwell B., et al. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987;213:2328.
  • 119
    Zimmerman BJ, Parks DA, Grisham MB, et al. Allopurinol does not enhance antioxidant properties of extracellular fluid. Am J Physiol 1988;255:H202H206.
  • 120
    Lochner F., Burrows SS, Shawley R., et al. Effects of allopurinol in experimental endotoxin shock in horses. Res Vet Sci 1989;47:178184.
  • 121
    Stone WC, Bjorling DE, Southard JH, et al. Evaluation of intestinal villus height in rats after ischemia and reperfusion by administration of superoxide dismutase, polethylene glycol-conjugated superoxide dismutase, and two 21-aminosteroids. Am J Vet Res 1992;53:21532156.
  • 122
    Wang J., Chen H., Wang T., et al. Oxygen-derived free radicals induced cellular injury in superior mesenteric artery occlusion shock: Protective effect of superoxide dismutase. Circ Shock 1990;32:3141.
  • 123
    Brayton CF. Dimethyl sulfoxide (DMSO): A review. Cornell Vet 1986;76:6190.
  • 124
    Schiller HJ, Reilly PM, Bulkley GB. Antioxidant therapy. Crit Care Med 1993;21:S92S102.
  • 125
    Raleigh JA, Kremers W. DMSO does not protect against hydrosyl radical induced peroxidation in model membranes. Int J Radial Biol 1981;39:441444.
  • 126
    Kono Y., Takahashi M., Asada K. Oxidation of manganous pyrophosphate by superoxide radicals and illuminated spinach chloroplasts. Arch Biochem Biophys 1976; 174:454462.
  • 127
    Archibald FS, Fridovich I. Manganese and defenses against oxygen toxicity in Lactobacillus plantarum. J Bacteriol 1981;145: 442451.
  • 128
    Singh RK, Kooreman KM, Babbs CF, Fessler JF, Salaris SC, Pham J. Potential use of simple manganese salts as antioxidant drugs in horses. Am J Vet Res. 1992;53: 18221829.
  • 129
    Keberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann NY Acad Sci. 1974;119: 758768.
  • 130
    Braughler J., Hall E., Jacobsen E., et al. The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs of the Future 1989;14:143151.
  • 131
    Hall E., Yonkers P., McCall J. Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006F. Eur J Pharmacol 1988; 147:299303.
  • 132
    Aoki N., Lefer A. Protective effects of a novel nonglucocor-ticoid 21-aminosteroid (U74006F) during traumatic shock in rats. J Cardio Pharmacol 1990; 15:205210.
  • 133
    Johnson G., Lefer A. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock. Circ Shock 1990;30:155164.
  • 134
    Badylak SF, Lantz GC, Jeffries M. Prevention of reperfusion injury in surgically induced gastric dilatation-volvulus in dogs. Am J Vet Res 1990;51:294299.
  • 135
    Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J 1989;3:3136.
  • 136
    Otamiri T., Tagesson C. Role of phospholipase A2 and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion. Am J Surg 1989; 157:562566.
  • 137
    Breitbart GB, Dillon PK, Suval WD, et al. Dexamethasone attenuates microvascular ischemia-reperfusion injury in the rat cremaster muscle. Microvasc Res 1989;38:155163.
  • 138
    Kubes P., Suzuki M., Granger DN. Modulation of PAF-in-duced leukocyte adherence and increased microvascular permeability. Am J Physiol 1990;259:G859G864.
  • 139
    Wilson DV, Eberhart SW, Robinson NE, et al. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086. Am J Vet Res 1993;54: 274279.
  • 140
    Wilson DV, Stick JA, Eberhart SW. The use of a specific platelet-activating factor antagonist in equine large colon torsion. Fourth Equine Colic Research Symposium 1991;34.
  • 141
    Wilson DV, Patterson JS, Stick JA, et al. Histologic and ultrastructural changes after large-colon torsion, with and without use of a specific platelet-activating factor antagonist (WEB 2086), in ponies. Am J Vet Res 1994;55: 681688.
  • 142
    Oz MC, Zikria BA, McLeod PF, et al. Hydroxyethyl starch macromolecules protect against increases in microvascular permeability following ischemia-reperfusion injury. Surg Forum 1989;40: 4850.
  • 143
    Zikria BA, Subbarao C., Oz MC, et al. Macromolecules reduce abnormal microvascular permeability in rat limb ischemiareperfusion injury. Crit Care Med 1989; 17:13061309.
  • 144
    Zikria BA, King TC, Stanford J., et al. A biophysical approach to capillary permeability. Surgery 1989; 105:625631.
  • 145
    Zikria BA, Subbarao C., Oz MC, et al. Hydroxyethyl starch macromolecules reduce myocardial reperfusion injury. Arch Surg 1990;125:930934.
  • 146
    Oz MC, Zikria BA, McLeod PF, Popilkis SJ. Hydroxyethyl starch macromolecule and superoxide dismutase effects on myocardial reperfusion injury. Am J Surg 1991; 162:5962.
  • 147
    Dabareiner RM, White NA, Lemasters JJ. Effect of reperfusion solution, “Carolina Rinse,” on intestinal vascular permeability and blood flow after jejunal and reperfusion in the horse. The Fifth Equine Colic Research Symposium 1994;28.